Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
National Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania.
Lancet. 2018 Apr 21;391(10130):1577-1588. doi: 10.1016/S0140-6736(18)30427-6. Epub 2018 Apr 11.
Progress in malaria control is under threat by wide-scale insecticide resistance in malaria vectors. Two recent vector control products have been developed: a long-lasting insecticidal net that incorporates a synergist piperonyl butoxide (PBO) and a long-lasting indoor residual spraying formulation of the insecticide pirimiphos-methyl. We evaluated the effectiveness of PBO long-lasting insecticidal nets versus standard long-lasting insecticidal nets as single interventions and in combination with the indoor residual spraying of pirimiphos-methyl.
We did a four-group cluster randomised controlled trial using a two-by-two factorial design of 48 clusters derived from 40 villages in Muleba (Kagera, Tanzania). We randomly assigned these clusters using restricted randomisation to four groups: standard long-lasting insecticidal nets, PBO long-lasting insecticidal nets, standard long-lasting insecticidal nets plus indoor residual spraying, or PBO long-lasting insecticidal nets plus indoor residual spraying. Both standard and PBO nets were distributed in 2015. Indoor residual spraying was applied only once in 2015. We masked the inhabitants of each cluster to the type of nets received, as well as field staff who took blood samples. Neither the investigators nor the participants were masked to indoor residual spraying. The primary outcome was the prevalence of malaria infection in children aged 6 months to 14 years assessed by cross-sectional surveys at 4, 9, 16, and 21 months after intervention. The endpoint for assessment of indoor residual spraying was 9 months and PBO long-lasting insecticidal nets was 21 months. This trial is registered with ClinicalTrials.gov, number NCT02288637.
7184 (68·0%) of 10 560 households were selected for post-intervention survey, and 15 469 (89·0%) of 17 377 eligible children from the four surveys were included in the intention-to-treat analysis. Of the 878 households visited in the two indoor residual spraying groups, 827 (94%) had been sprayed. Reported use of long-lasting insecticidal nets, across all groups, was 15 341 (77·3%) of 19 852 residents after 1 year, decreasing to 12 503 (59·2%) of 21 105 in the second year. Malaria infection prevalence after 9 months was lower in the two groups that received PBO long-lasting insecticidal nets than in the two groups that received standard long-lasting insecticidal nets (531 [29%] of 1852 children vs 767 [42%] of 1809; odds ratio [OR] 0·37, 95% CI 0·21-0·65; p=0·0011). At the same timepoint, malaria prevalence in the two groups that received indoor residual spraying was lower than in groups that did not receive indoor residual spraying (508 [28%] of 1846 children vs 790 [44%] of 1815; OR 0·33, 95% CI 0·19-0·55; p<0·0001) and there was evidence of an interaction between PBO long-lasting insecticidal nets and indoor residual spraying (OR 2·43, 95% CI 1·19-4·97; p=0·0158), indicating redundancy when combined. The PBO long-lasting insecticidal net effect was sustained after 21 months with a lower malaria prevalence than the standard long-lasting insecticidal net (865 [45%] of 1930 children vs 1255 [62%] of 2034; OR 0·40, 0·20-0·81; p=0·0122).
The PBO long-lasting insecticidal net and non-pyrethroid indoor residual spraying interventions showed improved control of malaria transmission compared with standard long-lasting insecticidal nets where pyrethroid resistance is prevalent and either intervention could be deployed to good effect. As a result, WHO has since recommended to increase coverage of PBO long-lasting insecticidal nets. Combining indoor residual spraying with pirimiphos-methyl and PBO long-lasting insecticidal nets provided no additional benefit compared with PBO long-lasting insecticidal nets alone or standard long-lasting insecticidal nets plus indoor residual spraying.
UK Department for International Development, Medical Research Council, and Wellcome Trust.
广泛存在的抗药性使疟疾控制的进展受到威胁。最近开发了两种新型的病媒控制产品:一种是含有增效剂增效醚(PBO)的长效杀虫蚊帐,另一种是长效室内滞留喷洒杀虫剂吡虫啉的配方。我们评估了 PBO 长效杀虫蚊帐与标准长效杀虫蚊帐作为单一干预措施以及与长效室内滞留喷洒吡虫啉联合使用的效果。
我们使用了一种由 40 个村庄中的 48 个集群组成的两因素、两水平的四组集群随机对照试验设计。我们采用限制性随机化方法将这些集群随机分配到四组:标准长效杀虫蚊帐、PBO 长效杀虫蚊帐、标准长效杀虫蚊帐加室内滞留喷洒、或 PBO 长效杀虫蚊帐加室内滞留喷洒。两种标准和 PBO 蚊帐均于 2015 年发放。2015 年仅进行了一次室内滞留喷洒。我们对每个集群的居民以及采集血液样本的现场工作人员都进行了分组方式的遮蔽。调查人员和参与者都没有对室内滞留喷洒进行遮蔽。主要结局是在干预后 4、9、16 和 21 个月通过横断面调查评估 6 个月至 14 岁儿童的疟疾感染流行率。评估室内滞留喷洒的终点是 9 个月,PBO 长效杀虫蚊帐是 21 个月。这项试验在 ClinicalTrials.gov 上注册,编号为 NCT02288637。
在 10560 户家庭中,有 7184 户(68.0%)被选中进行干预后调查,在四个调查中有 15469 名(89.0%)符合条件的 17377 名儿童中,有 15469 名(89.0%)被纳入意向治疗分析。在两个室内滞留喷洒组中,有 878 户家庭接受了喷洒,其中 827 户(94%)接受了喷洒。所有组别的长效杀虫蚊帐的实际使用率为 19852 名居民中的 15341 名(77.3%),一年后降至 21105 名中的 12503 名(59.2%)。与接受标准长效杀虫蚊帐的两组相比,接受 PBO 长效杀虫蚊帐的两组在 9 个月时的疟疾感染流行率较低(531 名儿童[29%]与 767 名儿童[42%];比值比[OR]0.37,95%置信区间[CI]0.21-0.65;p=0.0011)。同时,在接受室内滞留喷洒的两组中,疟疾流行率低于未接受室内滞留喷洒的两组(508 名儿童[28%]与 790 名儿童[44%];OR 0.33,95%CI 0.19-0.55;p<0.0001),且 PBO 长效杀虫蚊帐和室内滞留喷洒之间存在交互作用(OR 2.43,95%CI 1.19-4.97;p=0.0158),表明联合使用时存在冗余。在 21 个月后,PBO 长效杀虫蚊帐的效果持续存在,疟疾流行率低于标准长效杀虫蚊帐(865 名儿童[45%]与 1255 名儿童[62%];OR 0.40,0.20-0.81;p=0.0122)。
增效醚长效杀虫蚊帐和非拟除虫菊酯室内滞留喷洒干预措施与普遍存在的抗药性相比,控制疟疾传播的效果有所改善,且这两种干预措施都可以有效地实施。因此,世界卫生组织随后建议增加 PBO 长效杀虫蚊帐的覆盖率。与单独使用 PBO 长效杀虫蚊帐或标准长效杀虫蚊帐加室内滞留喷洒相比,室内滞留喷洒联合使用吡虫啉和 PBO 长效杀虫蚊帐并没有提供额外的益处。
英国国际发展部、医学研究理事会和惠康基金会。